Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Granulocyte macrophage colony-stimulating factor and interleukin 4 enhance the number and antigen-presenting activity of circulating CD14+ and CD83+ cells in cancer patients.
Roth MD, Gitlitz BJ, Kiertscher SM, Park AN, Mendenhall M, Moldawer N, Figlin RA. Roth MD, et al. Among authors: moldawer n. Cancer Res. 2000 Apr 1;60(7):1934-41. Cancer Res. 2000. PMID: 10766183 Clinical Trial.
A pilot trial of tumor lysate-loaded dendritic cells for the treatment of metastatic renal cell carcinoma.
Gitlitz BJ, Belldegrun AS, Zisman A, Chao DH, Pantuck AJ, Hinkel A, Mulders P, Moldawer N, Tso CL, Figlin RA. Gitlitz BJ, et al. Among authors: moldawer n. J Immunother. 2003 Sep-Oct;26(5):412-9. doi: 10.1097/00002371-200309000-00004. J Immunother. 2003. PMID: 12973030 Clinical Trial.
Phase I trial of granulocyte macrophage-colony stimulating factor and interleukin-4 as a combined immunotherapy for patients with cancer.
Gitlitz BJ, Figlin RA, Kiertscher SM, Moldawer N, Rosen F, Roth MD. Gitlitz BJ, et al. Among authors: moldawer n. J Immunother. 2003 Mar-Apr;26(2):171-8. doi: 10.1097/00002371-200303000-00010. J Immunother. 2003. PMID: 12616109 Clinical Trial.
Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients.
Figlin R, Gitlitz B, Franklin J, Dorey F, Moldawer N, Rausch J, deKernion J, Belldegrun A. Figlin R, et al. Among authors: moldawer n. Cancer J Sci Am. 1997 Dec;3 Suppl 1:S92-7. Cancer J Sci Am. 1997. PMID: 9457402 Clinical Trial.
Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor.
Figlin RA, Pierce WC, Kaboo R, Tso CL, Moldawer N, Gitlitz B, deKernion J, Belldegrun A. Figlin RA, et al. Among authors: moldawer n. J Urol. 1997 Sep;158(3 Pt 1):740-5. doi: 10.1097/00005392-199709000-00012. J Urol. 1997. PMID: 9258071 Clinical Trial.
Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinoma.
Belldegrun A, Pierce W, Kaboo R, Tso CL, Shau H, Turcillo P, Moldawer N, Golub S, deKernion J, Figlin R. Belldegrun A, et al. Among authors: moldawer n. J Urol. 1993 Nov;150(5 Pt 1):1384-90. doi: 10.1016/s0022-5347(17)35785-3. J Urol. 1993. PMID: 8411405 Clinical Trial.
Concomitant administration of recombinant human interleukin-2 and recombinant interferon alfa-2A: an active outpatient regimen in metastatic renal cell carcinoma.
Figlin RA, Belldegrun A, Moldawer N, Zeffren J, deKernion J. Figlin RA, et al. Among authors: moldawer n. J Clin Oncol. 1992 Mar;10(3):414-21. doi: 10.1200/JCO.1992.10.3.414. J Clin Oncol. 1992. PMID: 1482425 Clinical Trial.
A phase II trial of concomitant human interleukin-2 and interferon-alpha-2a in patients with disseminated malignant melanoma.
Whitehead RP, Figlin R, Citron ML, Pfile J, Moldawer N, Patel D, Jones G, Levitt D, Zeffren J. Whitehead RP, et al. Among authors: moldawer n. J Immunother Emphasis Tumor Immunol. 1993 Feb;13(2):117-21. doi: 10.1097/00002371-199302000-00006. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8318496 Clinical Trial.
The promise of recombinant interleukin-2.
Moldawer N, Carr E. Moldawer N, et al. Am J Nurs. 2000 May;100(5):35-9; quiz 40. Am J Nurs. 2000. PMID: 10823166 Review. No abstract available.
Treatment of metastatic renal cell carcinoma with high-dose bolus interleukin-2 in a non-intensive care unit: an analysis of 124 consecutively treated patients.
Gitlitz BJ, Hoffman DM, Moldawer N, Belldegrun A, Figlin RA. Gitlitz BJ, et al. Among authors: moldawer n. Cancer J. 2001 Mar-Apr;7(2):112-20. Cancer J. 2001. PMID: 11324764 Clinical Trial.
21 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback